“ Melatonin attenuated the … hepatic ASC concentrations and SOD, CAT and GSSG‐R activities and the increase in hepatic XO activity in a dose‐dependent manner without affecting … hepatic Se‐GSH‐Px activity or the increased hepatic VE concentration and G‐6‐PDH activity at 24 hr after CCl4 treatment.”
“These results indicate that melatonin postadministered at pharmacological doses prevents the disruption of hepatic ROS metabolism associated with ASC , SOD, CAT, GSSG‐R, and XO, in addition to reduced glutathione, in CCl4‐treated rats.”